larsucosterol
·Code: 25HC3S
larsucosterol: sourced relationships with 1 company · 1 clinical trial tracked.
larsucosterol evidence translation
What we can confirm
1 tracked trial
What it means
Source-backed records connect larsucosterol to DRRX; that link alone does not prove the drug works.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
How could larsucosterol → DRRX affect its developer, and what evidence supports the link?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Alcohol-associated hepatitis (AH)
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| DURECT CORP (DRRX) Alcohol-associated hepatitis (AH) | Phase 2 |
Clinical Trial Registry Records (1)
RE-AHFIRM (RandomizEd Study of Larsucosterol in Alcohol-associated Hepatitis to Confirm saFety and effIcacy of tReatMent)
Primary endpoint: Transplant Free Survival up to Day 90
InterventionalRandomizeddouble350 targetStarted 2026-01Completion 2028-0250 sites · United StatesBausch Health Americas, Inc.
Frequently asked questions
Which companies have sourced relationships with larsucosterol?
larsucosterol has dated SEC/FDA relationship records for DURECT CORP.
How many clinical trials involve larsucosterol?
BioSniper tracks 1 clinical trial involving larsucosterol.